Daryn Smith

1.5k citations

64 papers · 1.1k indexed · h-index 20

Impact in

Oncology top 10%
Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics

Papers in ⓘ

Pulmonary and Respiratory Medicine 32
- Prostate Cancer Treatment and Research 20
- Prostate Cancer Diagnosis and Treatment 5
Oncology 24
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 5

Co-authors: Lance K. Heilbrun (45 shared papers)Elisabeth I. Heath (23 shared papers)Patricia LoRusso (6 shared papers)Ulka N. Vaishampayan (24 shared papers)Michael S. Simon (4 shared papers)Philip A. Philip (4 shared papers)Lawrence E. Flaherty (2 shared papers)Cheryl A. Miree (1 shared paper)
Journals: Journal of Clinical Oncology (15 papers)Oncotarget (4 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Cancer (2 papers)Anti-Cancer Drugs (2 papers)
Partner nations: United States Canada France

In The Last Decade

Daryn Smith

62 papers receiving 1.1k citations

Peers

Countries citing papers authored by Daryn Smith

Since Specialization

Citations

This map shows the geographic impact of Daryn Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daryn Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daryn Smith more than expected).

Fields of papers citing papers by Daryn Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daryn Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daryn Smith. The network helps show where Daryn Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Daryn Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daryn Smith Line = papers co-authored together Daryn Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Factors Associated With Breast Cancer Clinical Trials Participation and Enrollment at a Large Academic Medical Center Journal of Clinical Oncology ·Michael S. Simon, Wei Du, Lawrence E. Flaherty, Philip A. Philip, Patricia LoRusso, Cheryl A. Miree, Daryn Smith, Diane R. Brown	2004	133
2	Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation Clinical Transplantation ·Teena Chopra, Pranatharthi Chandrasekar, Hossein Salimnia, Lance K. Heilbrun, Daryn Smith, George Alangaden	2010	81
3	Levels of 5-hydroxymethyl-2′-deoxyuridine in DNA from blood as a marker of breast cancer Cancer ·Zora Djurić, Lance K. Heilbrun, Michael S. Simon, Daryn Smith, Domenico A. Luongo, Patricia LoRusso, Silvana Martino	1996	52
4	A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma Oncotarget ·Priscila Gonçalves, Lance K. Heilbrun, Michael T. Barrett, Shivaani Kummar, Aaron R. Hansen, Lillian L. Siu, Richard Piekarz, Ammar Sukari, Joseph Chao, Mary Jo Pilat, Daryn Smith, Lindsay Casetta, Scott A. Boerner, Alice P. Chen, Elizabeth Lenkiewicz, Smriti Malasi, Patricia LoRusso	2017	50
5	Oxidative DNA Damage Levels in Blood from Women at High Risk for Breast Cancer are Associated with Dietary intakes of Meats, Vegetables, and Fruits Journal of the American Dietetic Association ·Zora Djurić, JANICE B DEPPER, Virginia Uhley, Daryn Smith, Samir Lababidi, Silvana Martino, Lance K. Heilbrun	1998	47
6	Galectin-3: a possible complementary marker to the PSA blood test Oncotarget ·Vitaly Balan, Yi Wang, Pratima Nangia‐Makker, Dhonghyo Kho, Madhuri Bajaj, Daryn Smith, Lance K. Heilbrun, Avraham Raz, Elisabeth I. Heath	2013	47
7	A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study Investigational New Drugs ·Manish Thakur, Lance K. Heilbrun, Shijie Sheng, Mark N. Stein, Glenn Liu, Emmanuel S. Antonarakis, Ulka N. Vaishampayan, Sijana H. Dzinic, Xiaohua Li, Stacy Freeman, Daryn Smith, Elisabeth I. Heath	2015	43
8	High Incidence of Severe Acute Graft-Versus-Host Disease with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplantation Patients Biology of Blood and Marrow Transplantation ·Zaid Al‐Kadhimi, Zartash Gul, Wei Chen, Daryn Smith, Muneer H. Abidi, Abhinav Deol, Lois Ayash, Lawrence G. Lum, Edmund K. Waller, Voravit Ratanatharathorn, Joseph P. Uberti	2014	38
9	Transcriptional Regulation of CXCR4 in Prostate Cancer: Significance of TMPRSS2-ERG Fusions Molecular Cancer Research ·Rajareddy Singareddy, Louie Semaan, M. Katie Conley‐LaComb, Jason St. John, Katelyn Powell, Matthew K. Iyer, Daryn Smith, Lance K. Heilbrun, Dongping Shi, Wael Sakr, Michael L. Cher, Sreenivasa R. Chinni	2013	35
10	Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer Urologic Oncology Seminars and Original Investigations ·Ulka N. Vaishampayan, Joseph A. Fontana, Lance K. Heilbrun, Daryn Smith, Elisabeth I. Heath, Brenda Dickow, William D. Figg	2013	30
11	Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study Urology ·Ulka N. Vaishampayan, Daniel H. Shevrin, Mark N. Stein, Lance K. Heilbrun, Susan Land, Karri Stark, Jing Li, Brenda Dickow, Elisabeth I. Heath, Daryn Smith, Joseph A. Fontana	2015	30
12	Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer JAMA Network Open ·Ulka N. Vaishampayan, Lance K. Heilbrun, Paul Monk, Sheela Tejwani, Guru Sonpavde, Clara Hwang, Daryn Smith, Pallavi Jasti, Kimberlee Dobson, Brenda Dickow, Elisabeth I. Heath, Louie Semaan, Michael L. Cher, Joseph A. Fontana, Sreenivasa R. Chinni	2021	28
13	Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature Bone Marrow Transplantation ·R. Ibrahim, E. Peres, Roger Dansey, Muneer H. Abidi, Esteban Abella, Mohamed Gumma, Nikki Milan, Daryn Smith, Lance K. Heilbrun, J Klein	2005	27
14	Randomized Phase II Study of Two Gemcitabine Schedules for Patients With Impaired Performance Status (Karnofsky performance status ≤ 70) and Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Sofia Baka, Linda Ashcroft, Heather Anderson, Michael Lind, P.A. Burt, R. Stout, I. Dowd, Daryn Smith, Paul Lorigan, Nicholas Thatcher	2005	27
15	The outcome of cancer patients with acute respiratory distress syndrome Journal of Critical Care ·Ayman O. Soubani, Emad Shehada, Wei Chen, Daryn Smith	2013	25
16	Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction Anti-Cancer Drugs ·Sachin Gupta, Venkata Parsa, Lance K. Heilbrun, Daryn Smith, Brenda Dickow, Elisabeth I. Heath, Ulka N. Vaishampayan	2011	23
17	Phase II Study of Celecoxib and Docetaxel in Non-small Cell Lung Cancer (NSCLC) Patients with Progression after Platinum-Based Therapy Journal of Thoracic Oncology ·Bryan J. Schneider, Gregory P. Kalemkerian, Michael Kraut, Antoinette J. Wozniak, Francis P. Worden, Daryn Smith, Wei Chen, Shirish M. Gadgeel	2008	21
18	Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers Gynecologic Oncology ·Robert Morris, Ronald D. Alvarez, Stephen Andrews, John Malone, Christopher S. Bryant, Lance K. Heilbrun, Daryn Smith, Veronica Schimp, Adnan Munkarah	2008	21
19	Squamous Cell Cancer of the Anal Canal in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy American Journal of Clinical Oncology ·Nazik Hammad, Lance K. Heilbrun, Sachin Gupta, Nishant Tageja, Philip A. Philip, Anthony F. Shields, Daryn Smith, Bassel F. El‐Rayes	2010	21
20	Positive associations between galectin-3 and PSA levels in prostate cancer patients: a prospective clinical study-I Oncotarget ·Kosei Nakajima, Lance K. Heilbrun, Victor Hogan, Daryn Smith, Elisabeth I. Heath, Avraham Raz	2016	20

About Daryn Smith

Daryn Smith is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 64 papers that have together received 1.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (20 papers), Cancer Treatment and Pharmacology (10 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Cancer Genomics and Diagnostics (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Heat shock proteins research (4 papers). The work is most often cited by research in Oncology (327 citations), Cancer Research (175 citations), Transplantation (29 citations), Pulmonary and Respiratory Medicine (293 citations) and Hematology (85 citations). Daryn Smith has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Lance K. Heilbrun, Elisabeth I. Heath, Patricia LoRusso, Ulka N. Vaishampayan, Michael S. Simon, Philip A. Philip, Lawrence E. Flaherty, Cheryl A. Miree, Diane R. Brown and Wei Du. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, International Journal of Radiation Oncology*Biology*Physics, Cancer and Anti-Cancer Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact